{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361418520872858752.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/s0029-7844(97)00668-6"}},{"identifier":{"@type":"URI","@value":"http://journals.lww.com/00006250-199803000-00006"}}],"dc:title":[{"@value":"Profile of women 45 years of age and younger with endometrial cancer*1"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381418520872858752","@type":"Researcher","foaf:name":[{"@value":"E EVANSMETCALF"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00297844"},{"@type":"PISSN","@value":"http://id.crossref.org/issn/00297844"}],"prism:publicationName":[{"@value":"Obstetrics & Gynecology"}],"dc:publisher":[{"@value":"Ovid Technologies (Wolters Kluwer Health)"}],"prism:publicationDate":"1998-03","prism:volume":"91","prism:number":"3","prism:startingPage":"349","prism:endingPage":"354"},"reviewed":"false","url":[{"@id":"http://journals.lww.com/00006250-199803000-00006"}],"createdAt":"2002-07-25","modifiedAt":"2024-11-14","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360009142615092864","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Prognostic Significance of Aberrant Claudin-6 Expression in Endometrial Cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848659559836672","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Family History and BRCA1/BRCA2 Status Among Japanese Ovarian Cancer Patients and Occult Cancer in a BRCA1 Mutant Case"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204696684032","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Clinicocytopathologic feature of endometrial carcinoma in young women"},{"@language":"ja","@value":"若年性子宮体がんの臨床病理細胞診断学的検討"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/s0029-7844(97)00668-6"},{"@type":"CROSSREF","@value":"10.1093/jjco/hyt171_references_DOI_GwsVr7GwQSLv88tHIW4k8i4IGVS"},{"@type":"CROSSREF","@value":"10.5795/jjscc.48.263_references_DOI_GwsVr7GwQSLv88tHIW4k8i4IGVS"},{"@type":"CROSSREF","@value":"10.3390/cancers12102748_references_DOI_GwsVr7GwQSLv88tHIW4k8i4IGVS"}]}